Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.

BMC Gastroenterol 2014 Oct 10;14:177. Epub 2014 Oct 10.

University of Wisconsin School of Medicine and Public Health, Aurora Summit Hospital, 36500 Aurora Drive, Summit WI 53066, USA.

Background: Partial response to proton pump inhibitor (PPI) therapy poses a healthcare challenge. This study aimed to compare symptom profiles in partial PPI responders and treatment-naïve patients with gastroesophageal reflux disease (GERD).

Methods: A post hoc analysis of data from two studies was performed. Partial PPI responders with GERD (n = 580; NCT00703534) had frequent (≥ 3 days/week) heartburn and/or regurgitation despite PPI therapy; patients with no improvement were excluded. Treatment-naïve patients with GERD (diagnosed by endoscopy and pH-metry; n = 203; NCT00291746) had frequent (≥ 3 days/week) upper gastrointestinal symptoms. The Gastrointestinal Symptom Rating Scale (GSRS) was completed by all patients at study entry and by treatment-naïve patients after PPI therapy.

Results: The highest (mean [95% confidence interval]) discomfort scores were reported in the Reflux (heartburn, regurgitation), Indigestion, and Abdominal pain domains of the GSRS, both in partial PPI responders (4.3 [4.2-4.4], 3.7 [3.6-3.8], and 3.4 [3.3-3.5], respectively) and in treatment-naïve patients (3.5 [3.3-3.7], 3.6 [3.4-3.7], and 3.1 [3.0-3.3], respectively). Partial PPI responders reported more discomfort than treatment-naïve patients in the Reflux, Abdominal pain, and Constipation domains (4.3 [4.2-4.4] vs. 3.5 [3.3-3.7], 3.4 [3.3-3.5] vs. 3.1 [3.0-3.3], and 2.5 [2.4-2.6] vs. 2.1 [1.9-2.2], respectively). All GSRS domain scores improved in treatment-naïve patients following PPI therapy.

Conclusions: Symptom patterns in partial PPI responders were similar to those in treatment-naïve patients with GERD, but partial PPI responders experienced more severe reflux, abdominal pain, and constipation than did treatment-naïve patients.

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-230X-14-177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287106PMC
October 2014
2 Reads

Publication Analysis

Top Keywords

treatment-naïve patients
36
partial ppi
24
ppi responders
24
abdominal pain
12
patients
11
ppi
10
treatment-naïve
9
reflux disease
8
≥ days/week
8
gastroesophageal reflux
8
frequent ≥
8
reflux abdominal
8
ppi therapy
8
responders treatment-naïve
8
patients ppi
8
patients gastroesophageal
8
pain constipation
8
hoc analysis
8
post hoc
8
pump inhibitor
8

References

(Supplied by CrossRef)

H El-Serag et al.
Aliment Pharmacol Ther 2010

S Toghanian et al.
Clin Drug Investig 2011

R Fass et al.
Aliment Pharmacol Ther 2005

GE Boeckxstaens et al.
Aliment Pharmacol Ther 2010

H Neumann et al.
Dig Dis 2008

LB Gerson et al.
Clin Gastroenterol Hepatol 2011

N Vakil et al.
Am J Gastroenterol 2006

N Vakil et al.
Am J Gastroenterol 2013

EM Quigley et al.
Nat Rev Gastroenterol Hepatol 2013

N de Bortoli et al.
World J Gastroenterol 2013

E Savarino et al.
Gut 2009

Similar Publications